FDA Inspection 1077487 — Janssen Biotech, Inc.
The FDA completed an inspection of Janssen Biotech, Inc. on November 30, 2018 in Malvern, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 30, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Malvern, PA (United States)
Additional Details
Sponsor, Contract Research Organization